JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 32 No. 4 623-648
© 1991 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strauss, L. G.
Right arrow Articles by Conti, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strauss, L. G.
Right arrow Articles by Conti, P. S.

The Applications of PET in Clinical Oncology

Ludwig G. Strauss and Peter S. Conti

Institute of Radiology and Pathophysiology, German Cancer Research Center, Heidelberg, Germany
Department of Radiology and Radiological Sciences, The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For reprints contact: Peter S. Conti, MD, PhD, Department of Radiology and Radiological Sciences, The Johns Hopkins Hospital, 600 N. Wolfe St., Baltimore, MD 21205.

ABSTRACT

With the advent of a new generation of PET scanners that have introduced whole-body PET to the clinical setting, there is now more interest in developing protocols for the evaluation of both intracranial and somatic cancers. The value of PET in clinical oncology has been demonstrated with studies in a variety of cancers including colorectal carcinomas, lung tumors, head and neck tumors, primary and metastatic brain tumors, breast carcinoma, lymphoma, melanoma, bone cancers, and other soft-tissue cancers. A summary of current clinical applications of PET in oncology is presented with special attention to colorectal, lung, and intracranial neoplasms since the majority of clinical trials have focused on these cancers. A variety of radiopharmaceuticals are described that are currently included in clinical tumor-imaging protocols, including metabolic substrates such as fluorine-18-fluorodeoxyglucose and carbon-11-methionine, and analogs of chemotherapeutic agents such as fluorine-18-fluorouracil and fluoroestradiol. An attempt is also made to include examples of clinical trials that demonstrate response to therapeutic intervention. The increasing number of oncologic PET studies reflects the growing interest in functional imaging in oncology.




This article has been cited by other articles:


Home page
 JCOHome page
K. Oechsle, M. Hartmann, W. Brenner, S. Venz, L. Weissbach, C. Franzius, S. Kliesch, S. Mueller, S. Krege, R. Heicappell, et al.
[18F]Fluorodeoxyglucose Positron Emission Tomography in Nonseminomatous Germ Cell Tumors After Chemotherapy: The German Multicenter Positron Emission Tomography Study Group
J. Clin. Oncol., December 20, 2008; 26(36): 5930 - 5935.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. G. Strauss, D. Koczan, S. Klippel, L. Pan, C. Cheng, S. Willis, U. Haberkorn, and A. Dimitrakopoulou-Strauss
Impact of Angiogenesis-Related Gene Expression on the Tracer Kinetics of 18F-FDG in Colorectal Tumors
J. Nucl. Med., August 1, 2008; 49(8): 1238 - 1244.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
A. Dimitrakopoulou-Strauss, P. Hohenberger, U. Haberkorn, H. R. Macke, M. Eisenhut, and L. G. Strauss
68Ga-Labeled Bombesin Studies in Patients with Gastrointestinal Stromal Tumors: Comparison with 18F-FDG
J. Nucl. Med., August 1, 2007; 48(8): 1245 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Y. Kim, S.-w. Lee, S. Y. Nam, K. C. Im, J.-S. Kim, S. J. Oh, S. D. Ahn, S. S. Shin, E. K. Choi, and J. H. Kim
The Feasibility of 18F-FDG PET Scans 1 Month After Completing Radiotherapy of Squamous Cell Carcinoma of the Head and Neck
J. Nucl. Med., March 1, 2007; 48(3): 373 - 378.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
O. Israel and A. Kuten
Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference in Diagnosis and Patient Care
J. Nucl. Med., January 1, 2007; 48(1_suppl): 28S - 35S.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
A. Quon, S. Napel, C. F. Beaulieu, and S. S. Gambhir
"Flying Through" and "Flying Around" a PET/CT Scan: Pilot Study and Development of 3D Integrated 18F-FDG PET/CT for Virtual Bronchoscopy and Colonoscopy
J. Nucl. Med., July 1, 2006; 47(7): 1081 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. R. Davies, J. H.F. Rudd, P. L. Weissberg, and J. Narula
Radionuclide imaging for the detection of inflammation in vulnerable plaques.
J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C57 - C68.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
S. Yamaguchi, H. Rikimaru, K. Yamaguchi, M. Itoh, and M. Watanabe
Overall Activity of All Masticatory Muscles during Lateral Excursion
J. Dent. Res., January 1, 2006; 85(1): 69 - 73.
[Abstract] [Full Text] [PDF]

Home page
 FAKE JDRHome page
S. Yamaguchi, H. Rikimaru, K. Yamaguchi, M. Itoh, and M. Watanabe
Overall Activity of All Masticatory Muscles during Lateral Excursion
Journal of Dental Research, January 1, 2006; 85(1): 69 - 73.
[Abstract] [Full Text] [PDF]

Home page
 J Bone Joint Surg BrHome page
P. Reinartz, T. Mumme, B. Hermanns, U. Cremerius, D. C. Wirtz, W. M. Schaefer, F.-U. Niethard, and U. Buell
Radionuclide imaging of the painful hip arthroplasty: POSITRON-EMISSION TOMOGRAPHY VERSUS TRIPLE-PHASE BONE SCANNING
J Bone Joint Surg Br, April 1, 2005; 87-B(4): 465 - 470.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. R. Davies, J. H. Rudd, and P. L. Weissberg
Molecular and Metabolic Imaging of Atherosclerosis
J. Nucl. Med., November 1, 2004; 45(11): 1898 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
A. Dimitrakopoulou-Strauss, L. G. Strauss, C. Burger, A. Ruhl, G. Irngartinger, W. Stremmel, and J. Rudi
Prognostic Aspects of 18F-FDG PET Kinetics in Patients with Metastatic Colorectal Carcinoma Receiving FOLFOX Chemotherapy
J. Nucl. Med., September 1, 2004; 45(9): 1480 - 1487.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. G. Strauss, A. Dimitrakopoulou-Strauss, D. Koczan, L. Bernd, U. Haberkorn, V. Ewerbeck, and H.-J. Thiesen
18F-FDG Kinetics and Gene Expression in Giant Cell Tumors
J. Nucl. Med., September 1, 2004; 45(9): 1528 - 1535.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. Guo, K. Higashi, H. Yokota, Y. Nagao, Y. Ueda, Y. Kodama, M. Oguchi, S. Taki, H. Tonami, and I. Yamamoto
In Vitro Proton Magnetic Resonance Spectroscopic Lactate and Choline Measurements, 18F-FDG Uptake, and Prognosis in Patients with Lung Adenocarcinoma
J. Nucl. Med., August 1, 2004; 45(8): 1334 - 1339.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. G. Strauss, A. Dimitrakopoulou-Strauss, and U. Haberkorn
Shortened PET Data Acquisition Protocol for the Quantification of 18F-FDG Kinetics
J. Nucl. Med., December 1, 2003; 44(12): 1933 - 1939.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Takahashi, Y. Imahori, and K. Mineura
Prognostic and Therapeutic Indicator of Fluoroboronophenylalanine Positron Emission Tomography in Patients with Gliomas
Clin. Cancer Res., December 1, 2003; 9(16): 5888 - 5895.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S.-Y. Ma, L.-C. See, C.-H. Lai, H.-H. Chou, C.-S. Tsai, K.-K. Ng, S. Hsueh, W.-J. Lin, J.-T. Chen, and T.-C. Yen
Delayed 18F-FDG PET for Detection of Paraaortic Lymph Node Metastases in Cervical Cancer Patients
J. Nucl. Med., November 1, 2003; 44(11): 1775 - 1783.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
N Khan, N Oriuchi, T Higuchi, H Zhang, and K Endo
PET in the follow-up of differentiated thyroid cancer
Br. J. Radiol., October 1, 2003; 76(910): 690 - 695.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. W. Kang, S.-K. Kim, H.-S. Kang, E. S. Lee, J. S. Sim, I. G. Lee, S.-Y. Jeong, and S. W. Kim
Prevalence and Risk of Cancer of Focal Thyroid Incidentaloma Identified by 18F-Fluorodeoxyglucose Positron Emission Tomography for Metastasis Evaluation and Cancer Screening in Healthy Subjects
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4100 - 4104.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
E. L. Bravo and R. Tagle
Pheochromocytoma: State-of-the-Art and Future Prospects
Endocr. Rev., August 1, 2003; 24(4): 539 - 553.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. Koyama, T. Okamura, J. Kawabe, N. Ozawa, K. Torii, N. Umesaki, M. Miyama, H. Ochi, and R. Yamada
Evaluation of 18F-FDG PET with Bladder Irrigation in Patients with Uterine and Ovarian Tumors
J. Nucl. Med., March 1, 2003; 44(3): 353 - 358.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
Y. Kitagawa, S. Nishizawa, K. Sano, T. Ogasawara, M. Nakamura, N. Sadato, M. Yoshida, and Y. Yonekura
Prospective Comparison of 18F-FDG PET with Conventional Imaging Modalities (MRI, CT, and 67Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma
J. Nucl. Med., February 1, 2003; 44(2): 198 - 206.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
H.-J. Jeong, J.-K. Chung, Y. K. Kim, C. Y. Kim, D. G. Kim, J. M. Jeong, D. S. Lee, H. W. Jung, and M. C. Lee
Usefulness of Whole-Body 18F-FDG PET in Patients with Suspected Metastatic Brain Tumors
J. Nucl. Med., November 1, 2002; 43(11): 1432 - 1437.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
B. G.M. Durie, A. D. Waxman, A. D'Agnolo, and C. M. Williams
Whole-Body 18F-FDG PET Identifies High-Risk Myeloma
J. Nucl. Med., November 1, 2002; 43(11): 1457 - 1463.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
O. Israel, M. Mor, D. Gaitini, Z. Keidar, L. Guralnik, A. Engel, A. Frenkel, R. Bar-Shalom, and A. Kuten
Combined Functional and Structural Evaluation of Cancer Patients with a Hybrid Camera-Based PET/CT System Using 18F-FDG
J. Nucl. Med., September 1, 2002; 43(9): 1129 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
E. Even-Sapir, H. Lerman, A. Figer, M. Rabau, G. Livshitz, M. Inbar, and M. Gutman
Role of 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging in Recurrent or Metastatic Colorectal Carcinoma
J. Nucl. Med., May 1, 2002; 43(5): 603 - 609.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
A. Dimitrakopoulou-Strauss, L. G. Strauss, T. Heichel, H. Wu, C. Burger, L. Bernd, and V. Ewerbeck
The Role of Quantitative 18F-FDG PET Studies for the Differentiation of Malignant and Benign Bone Lesions
J. Nucl. Med., April 1, 2002; 43(4): 510 - 518.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Higashi, T. Saga, Y. Nakamoto, T. Ishimori, M. H. Mamede, M. Wada, R. Doi, R. Hosotani, M. Imamura, and J. Konishi
Relationship Between Retention Index in Dual-Phase 18F-FDG PET, and Hexokinase-II and Glucose Transporter-1 Expression in Pancreatic Cancer
J. Nucl. Med., February 1, 2002; 43(2): 173 - 180.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
N. Oyama, H. Akino, H. Kanamaru, Y. Suzuki, S. Muramoto, Y. Yonekura, N. Sadato, K. Yamamoto, and K. Okada
11C-Acetate PET Imaging of Prostate Cancer
J. Nucl. Med., February 1, 2002; 43(2): 181 - 186.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Samnick, J. B. Bader, D. Hellwig, J. R. Moringlane, C. Alexander, B. F.M. Romeike, W. Feiden, and C.-M. Kirsch
Clinical Value of Iodine-123-Alpha-Methyl-L-Tyrosine Single-Photon Emission Tomography in the Differential Diagnosis of Recurrent Brain Tumor in Patients Pretreated for Glioma at Follow-Up
J. Clin. Oncol., January 15, 2002; 20(2): 396 - 404.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Nunez, H. A. Macapinlac, H. W.D. Yeung, T. Akhurst, S. Cai, I. Osman, M. Gonen, E. Riedel, H. I. Scher, and S. M. Larson
Combined 18F-FDG and 11C-Methionine PET Scans in Patients with Newly Progressive Metastatic Prostate Cancer
J. Nucl. Med., January 1, 2002; 43(1): 46 - 55.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Szakall Jr., O. Esik, G. Bajzik, I. Repa, G. Dabasi, I. Sinkovics, P. Agoston, and L. Tron
18F-FDG PET Detection of Lymph Node Metastases in Medullary Thyroid Carcinoma
J. Nucl. Med., January 1, 2002; 43(1): 66 - 71.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
B. O. Helal, P. Merlet, M.-E. Toubert, B. Franc, C. Schvartz, H. Gauthier-Koelesnikov, A. Prigent, and A. Syrota
Clinical Impact of 18F-FDG PET in Thyroid Carcinoma Patients with Elevated Thyroglobulin Levels and Negative 131I Scanning Results After Therapy
J. Nucl. Med., October 1, 2001; 42(10): 1464 - 1469.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Mochizuki, E. Tsukamoto, Y. Kuge, K. Kanegae, S. Zhao, K. Hikosaka, M. Hosokawa, M. Kohanawa, and N. Tamaki
FDG Uptake and Glucose Transporter Subtype Expressions in Experimental Tumor and Inflammation Models
J. Nucl. Med., October 1, 2001; 42(10): 1551 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 FAKE JDRHome page
H. Rikimaru, M. Kikuchi, M. Itoh, M. Tashiro, and M. Watanabe
Mapping Energy Metabolism in Jaw and Tongue Muscles during Chewing
Journal of Dental Research, September 1, 2001; 80(9): 1849 - 1853.
[Abstract] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. S. Keppler and P. S. Conti
A Cost Analysis of Positron Emission Tomography
Am. J. Roentgenol., July 1, 2001; 177(1): 31 - 40.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. Aoki, H. Watanabe, T. Shinozaki, K. Takagishi, H. Ishijima, N. Oya, N. Sato, T. Inoue, and K. Endo
FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions
Radiology, June 1, 2001; 219(3): 774 - 777.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
A. Dimitrakopoulou-Strauss, L. G. Strauss, M. Schwarzbach, C. Burger, T. Heichel, F. Willeke, G. Mechtersheimer, and T. Lehnert
Dynamic PET 18F-FDG Studies in Patients with Primary and Recurrent Soft-Tissue Sarcomas: Impact on Diagnosis and Correlation with Grading
J. Nucl. Med., May 1, 2001; 42(5): 713 - 720.
[Abstract] [Full Text]

Home page
 JNMHome page
A. Dimitrakopoulou-Strauss, L. G. Strauss, and C. Burger
Quantitative PET Studies in Pretreated Melanoma Patients: A Comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 15O-Water Using Compartment and Noncompartment Analysis
J. Nucl. Med., February 1, 2001; 42(2): 248 - 256.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
K. Kim, S. J. Park, B.-T. Kim, K. S. Lee, and Y. M. Shim
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography
Ann. Thorac. Surg., January 1, 2001; 71(1): 290 - 294.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. A. Lodge, R. E. Carson, J. A. Carrasquillo, M. Whatley, S. K. Libutti, and S. L. Bacharach
Parametric Images of Blood Flow in Oncology PET Studies Using [15O]Water
J. Nucl. Med., November 1, 2000; 41(11): 1784 - 1792.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. A.D. Smith, N. R. Maisey, J. C. Titley, L. E. Jackson, M. O. Leach, and S. M. Ronen
Treatment of SW620 Cells with Tomudex and Oxaliplatin Induces Changes in 2-Deoxy-D-Glucose Incorporation Associated with Modifications in Glucose Transport
J. Nucl. Med., October 1, 2000; 41(10): 1753 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
J. M. Wilmshurst, S. F. Barrington, D. Pritchard, T. Cox, P. Bullock, M. Maisey, and R. O. Robinson
Positron Emission Tomography in Imaging Spinal Cord Tumors
J Child Neurol, July 1, 2000; 15(7): 465 - 472.
[Abstract] [PDF]

Home page
 JCOHome page
I. C. Smith, A. E. Welch, A. W. Hutcheon, I. D. Miller, S. Payne, F. Chilcott, S. Waikar, T. Whitaker, A. K. Ah-See, O. Eremin, et al.
Positron Emission Tomography Using [18F]-Fluorodeoxy-D-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
J. Clin. Oncol., April 1, 2000; 18(8): 1676 - 1688.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. F. Patz Jr
Imaging Bronchogenic Carcinoma
Chest, April 1, 2000; 117(4_suppl_1): 90S - 95S.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
R E Ferner, J D Lucas, M J O'Doherty, R A C Hughes, M A Smith, B F Cronin, and J Bingham
Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1
J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 353 - 357.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
J. J. Erasmus, H. P. McAdams, and J. E. Connolly
Solitary Pulmonary Nodules: Part II. Evaluation of the Indeterminate Nodule
RadioGraphics, January 1, 2000; 20(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
J. Mernagh and S. Somers
A new way to look at inflammatory bowel disease
Can. Med. Assoc. J., November 1, 1999; 161(9): 1139 - 1139.
[Full Text] [PDF]

Home page
 RadiologyHome page
Y. Sugawara, K. R. Zasadny, A. W. Neuhoff, and R. L. Wahl
Reevaluation of the Standardized Uptake Value for FDG: Variations with Body Weight and Methods for Correction
Radiology, November 1, 1999; 213(2): 521 - 525.
[Abstract] [Full Text]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. U Berlangieri, A. M Scott, S. R Knight, G. J Fitt, O. F Hennessy, H. J Tochon-Danguy, C Peter Clarke, and W John McKay
F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 1999; 16(suppl_1): S25 - S30.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Dimitrakopoulou-Strauss, L. G. Strauss, F. Gutzler, G. Irngartinger, G. Kontaxakis, D. K. Kim, F. Oberdorfer, and G. van Kaick
Pharmacokinetic Imaging of 11C Ethanol with PET in Eight Patients with Hepatocellular Carcinomas Who Were Scheduled for Treatment with Percutaneous Ethanol Injection
Radiology, June 1, 1999; 211(3): 681 - 686.
[Abstract] [Full Text]

Home page
 ChestHome page
S. T. Mastin, W. E. Drane, E. M. Harman, J. J. Fenton, and L. Quesenberry
FDG SPECT in Patients With Lung Masses
Chest, April 1, 1999; 115(4): 1012 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. B. Hathaway, D. A. Mankoff, K. R. Maravilla, M. M. Austin-Seymour, G. K. Ellis, J. R. Gralow, A. A. Cortese, C. E. Hayes, and R. E. Moe
Value of Combined FDG PET and MR Imaging in the Evaluation of Suspected Recurrent Local-Regional Breast Cancer: Preliminary Experience
Radiology, March 1, 1999; 210(3): 807 - 814.
[Abstract] [Full Text]

Home page
 JCOHome page
P. G. Rose, L. P. Adler, M. Rodriguez, P. F. Faulhaber, F. W. Abdul-Karim, and F. Miraldi
Positron Emission Tomography for Evaluating Para-aortic Nodal Metastasis in Locally Advanced Cervical Cancer Before Surgical Staging: A Surgicopathologic Study
J. Clin. Oncol., January 1, 1999; 17(1): 41 - 41.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. Romer, A.-R. Hanauske, S. Ziegler, R. Thodtmann, W. Weber, C. Fuchs, W. Enne, M. Herz, C. Nerl, M. Garbrecht, et al.
Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose
Blood, June 15, 1998; 91(12): 4464 - 4471.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. G. Strauss
Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology
Oncologist, December 1, 1997; 2(6): 381 - 388.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. D. Luketich, P. R. Schauer, C. C. Meltzer, R. J. Landreneau, G. K. Urso, D. W. Townsend, P. F. Ferson, R. J. Keenan, and C. P. Belani
Role of Positron Emission Tomography in Staging Esophageal Cancer
Ann. Thorac. Surg., September 1, 1997; 64(3): 765 - 769.
[Abstract] [Full Text]

Home page
 Arch Otolaryngol Head Neck SurgHome page
C. Reisser, U. Haberkorn, A. Dimitrakopoulou-Strauss, E. Seifert, and L. G. Strauss
Chemotherapeutic Management of Head and Neck Malignancies With Positron Emission Tomography
Arch Otolaryngol Head Neck Surg, March 1, 1995; 121(3): 272 - 276.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1991 by the Society of Nuclear Medicine.